{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:16:25Z","timestamp":1768346185091,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,24]]},"DOI":"10.7759\/cureus.72254","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T08:39:34Z","timestamp":1729759174000},"source":"Crossref","is-referenced-by-count":2,"title":["Use of Therapeutic Plasma Exchange and Intravenous Immunoglobulin to Prevent Complications in a K+ Sensitized Pregnancy"],"prefix":"10.7759","author":[{"given":"Mary D","family":"Hanson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren","family":"Groh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Barsoom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-05329-z","article-title":"Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape","volume":"23","author":"de Winter DP","year":"2023","unstructured":"de Winter DP, Kaminski A, Tjoa ML, Oepkes D. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth. 2023, 23:12. 10.1186\/s12884-022-05329-z","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2011.06.014","article-title":"Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion","volume":"45","author":"Lakhwani S","year":"2011","unstructured":"Lakhwani S, Machado P, Pecos P, Coloma M, Rebollo S, Raya JM. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion. Transfus Apher Sci. 2011, 45:9-11. 10.1016\/j.transci.2011.06.014","journal-title":"Transfus Apher Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.07.014","article-title":"Fetal blood sampling","volume":"209","author":"Berry SM","year":"2013","unstructured":"Berry SM, Stone J, Norton ME, Johnson D, Berghella V. Fetal blood sampling. Am J Obstet Gynecol. 2013, 209:170-80. 10.1016\/j.ajog.2013.07.014","journal-title":"Am J Obstet Gynecol"},{"key":"ref4","article-title":"Fetal Blood Sampling","author":"Ghidini A","year":"2022","unstructured":"Ghidini A. Fetal Blood Sampling. UpToDate. UpToDate, Waltham, MA; 2022."},{"key":"ref5","article-title":"Intrauterine fetal transfusion of red cells","author":"Moise Jr KJ","year":"2023","unstructured":"Moise Jr KJ. Intrauterine fetal transfusion of red cells. UpToDate. UpToDate, Waltham, MA; 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures","volume":"50","author":"Zwiers C","year":"2017","unstructured":"Zwiers C, Lindenburg IT, Klumper FJ, de Haas M, Oepkes D, Van Kamp IL. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol. 2017, 50:180-6. 10.1002\/uog.17319","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000490154","article-title":"Efficacy of antenatal intravenous immunoglobulin treatment in pregnancies at high risk due to alloimmunization to red blood cells","volume":"45","author":"Mayer B","year":"2018","unstructured":"Mayer B, Hinkson L, Hillebrand W, Henrich W, Salama A. Efficacy of antenatal intravenous immunoglobulin treatment in pregnancies at high risk due to alloimmunization to red blood cells. Transfus Med Hemother. 2018, 45:429-36. 10.1159\/000490154","journal-title":"Transfus Med Hemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization","volume":"196","author":"Ruma MS","year":"2007","unstructured":"Ruma MS, Moise KJ Jr, Kim E, Murtha AP, Prutsman WJ, Hassan SS, Lubarsky SL. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol. 2007, 196:138.e1-6. 10.1016\/j.ajog.2006.10.890","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14453","article-title":"Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion","volume":"58","author":"Nwogu LC","year":"2018","unstructured":"Nwogu LC, Moise KJ Jr, Klein KL, Tint H, Castillo B, Bai Y. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion. Transfusion. 2018, 58:677-84. 10.1111\/trf.14453","journal-title":"Transfusion"},{"key":"ref10","article-title":"The Kell blood group","author":"Dean L","year":"2005","unstructured":"Dean L. The Kell blood group. Blood Groups and Red Cell Antigens.  National Center for Biotechnology Information, Bethesda, MD; 2005."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000260957.77090.4e","article-title":"Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy","volume":"109","author":"van Wamelen DJ","year":"2007","unstructured":"van Wamelen DJ, Klumper FJ, de Haas M, Meerman RH, van Kamp IL, Oepkes D. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy. Obstet Gynecol. 2007, 109:1093-8. 10.1097\/01.AOG.0000260957.77090.4e","journal-title":"Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2001.00021.x","article-title":"Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients","volume":"80","author":"Fern\u00e1ndez-Jim\u00e9nez MC","year":"2001","unstructured":"Fern\u00e1ndez-Jim\u00e9nez MC, Jim\u00e9nez-Marco MT, Hern\u00e1ndez D, Gonz\u00e1lez A, Ome\u00f1aca F, de la C\u00e1mara C. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang. 2001, 80:117-20. 10.1046\/j.1423-0410.2001.00021.x","journal-title":"Vox Sang"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.07.020","article-title":"Predicting anti-Kell-mediated hemolytic disease of\u00a0the\u00a0fetus and newborn: diagnostic accuracy of laboratory management","volume":"219","author":"Slootweg YM","year":"2018","unstructured":"Slootweg YM, Lindenburg IT, Koelewijn JM, Van Kamp IL, Oepkes D, De Haas M. Predicting anti-Kell-mediated hemolytic disease of\u00a0the\u00a0fetus and newborn: diagnostic accuracy of laboratory management. Am J Obstet Gynecol. 2018, 219:393.e1-8. 10.1016\/j.ajog.2018.07.020","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","article-title":"Management of non-RhD red blood cell alloantibodies during pregnancy","author":"Moise Jr KJ","year":"2024","unstructured":"Moise Jr KJ, Ward D. Management of non-RhD red blood cell alloantibodies during pregnancy. UpToDate. UpToDate, Waltham, MA; 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/00016340802268880","article-title":"Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden","volume":"87","author":"Gottvall T","year":"2008","unstructured":"Gottvall T, Filbey D. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden. Acta Obstet Gynecol Scand. 2008, 87:843-8. 10.1080\/00016340802268880","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200608000-00044","article-title":"ACOG Practice Bulletin No. 75: Management of alloimmunization during pregnancy","volume":"108","year":"2006","unstructured":"ACOG Practice Bulletin No. 75. Management of alloimmunization during pregnancy. Obstet Gynecol. 2006, 108:457-64. 10.1097\/00006250-200608000-00044","journal-title":"Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American Society for Apheresis: the eight special issue","volume":"34","author":"Padmanabhan A","year":"2019","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N, et al.. Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the American Society for Apheresis: the eight special issue. J Clin Apher. 2019, 34:171-354. 10.1002\/jca.21705","journal-title":"J Clin Apher"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a\u00a0review of evidence","volume":"139","author":"Perez EE","year":"2017","unstructured":"Perez EE, Orange JS, Bonilla F, et al.. Update on the use of immunoglobulin in human disease: a\u00a0review of evidence. J Allergy Clin Immunol. 2017, 139:S1-S46. 10.1016\/j.jaci.2016.09.023","journal-title":"J Allergy Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000503937","article-title":"Recommendations for therapeutic apheresis by the section \"Preparative and Therapeutic Hemapheresis\" of the German Society for Transfusion Medicine and Immunohematology","volume":"46","author":"Worel N","year":"2019","unstructured":"Worel N, Mansouri Taleghani B, Strasser E. Recommendations for therapeutic apheresis by the section \"Preparative and Therapeutic Hemapheresis\" of the German Society for Transfusion Medicine and Immunohematology. Transfus Med Hemother. 2019, 46:394-406. 10.1159\/000503937","journal-title":"Transfus Med Hemother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.10.025","article-title":"Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and\u00a0newborn","volume":"220","author":"Maisonneuve E","year":"2019","unstructured":"Maisonneuve E, Toly-Ndour C, Jouannic JM. Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and\u00a0newborn. Am J Obstet Gynecol. 2019, 220:288. 10.1016\/j.ajog.2018.10.025","journal-title":"Am J Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.06.007","article-title":"Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and newborn","volume":"219","author":"Zwiers C","year":"2018","unstructured":"Zwiers C, van der Bom JG, van Kamp IL, et al.. Postponing early intrauterine transfusion with intravenous immunoglobulin treatment: the PETIT study on severe hemolytic disease of the fetus and newborn. Am J Obstet Gynecol. 2018, 219:291.e1-9. 10.1016\/j.ajog.2018.06.007","journal-title":"Am J Obstet Gynecol"},{"key":"ref22","article-title":"Intravenous immunoglobulin (IVIG)","author":"Arumugham VB","year":"2024","unstructured":"Arumugham VB, Rayi A. Intravenous immunoglobulin (IVIG). StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20180","article-title":"Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy","volume":"23","author":"Novak DJ","year":"2008","unstructured":"Novak DJ, Tyler LN, Reddy RL, Barsoom MJ. Plasmapheresis and intravenous immune globulin for the treatment of D alloimmunization in pregnancy. J Clin Apher. 2008, 23:183-5. 10.1002\/jca.20180","journal-title":"J Clin Apher"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/310002-use-of-therapeutic-plasma-exchange-and-intravenous-immunoglobulin-to-prevent-complications-in-a-k-sensitized-pregnancy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T08:39:36Z","timestamp":1729759176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/310002-use-of-therapeutic-plasma-exchange-and-intravenous-immunoglobulin-to-prevent-complications-in-a-k-sensitized-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.72254","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}